Medicon Village Academy: Using technology to enhance your clinical trials strategy
Register now to join Huma at a Medicon Village Academy session, where you will have the opportunity to learn how our award winning technology will allow you to improve your strategy for your next clinical trials in the areas of:
- Patient recruitment
- Patient engagement
- Data collection (from eCOA/ePRO, connected devices, and Consenting capabilities)
- Patient adherence (to both protocol and treatment).
During the session you will learn how our decentralized/hybrid clinical trial platform reduces costs and patient burden, allows for the collection of high-quality data in a regulated and efficient manner and accelerates timelines to deliver more patient-centric research.
Program
12.30 – 13.00 Audience arrive & get lunch
13.00 – 13.05 Welcome by Medicon Village and Huma
13.05 – 14.00 Intro on Huma and its capabilities on:
- Patient recruitment and engagement
- Data collection (eConsent, eCOA/ePRO, Connected Devices Adverse events)
- General capabilities (Telemedicine, Learning portal) and DEMO
Speaker: Dennis Velasquez, VP, Commercial, DCT, Huma
14.00 – 14.30 Oncology and technology in clinical trials
Challenges and how to overcome
Speaker: Simon Chowdhury, Clinical Director Oncology, Huma
14.30 – 15.00 Coffee break & Networking
15.00 – 15.30 Different Therapeutic Area challenges and solutions – Huma’s approach to DCT
Speaker: Arrash Yassaee, Global Clinical Director – Evidence Generation and IG, Huma
15.30 – 16.00 Panel discussion and Q&A
16.00 – Networking
About Huma
Huma Therapeutics is a global digital health company headquartered in the UK that advances digital-first care delivery and research to help people live longer, fuller lives. Huma’s award-winning modular platforms are used by more than 3,000 hospitals and clinics, with 1.8 million active users. Huma’s offering works across different disease areas and powers:
- ‘Hospitals at Home’
- Software as a Medical Device (SaMD) solutions
- Decentralized Clinical Trial (DCT) platform to support digital or hybrid studies
Huma’s platform has been shown to almost double clinical capacity, reduce readmissions by over a third, enable better diversity, participant retention and protocol adherence, whilst allowing trials to run within weeks. Please visit www.huma.com and follow us on LinkedIn at Huma.
About Medicon Village Academy
Medicon Village Academy is an educational meeting concept for sharing life science knowledge.